CLOs on the Move

American College of Gastroenterology

www.gi.org

 
The American College of Gastroenterology is a professional organization with an international membership of over 17,000 individuals from 86 countries. The College provides its members with the most accurate and up to date scientific information on dige...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.gi.org
  • 6400, Goldsboro Road
    Bethesda, MD USA 20817
  • Phone: 301.263.9000

Executives

Name Title Contact Details

Similar Companies

Recovree

We help people find and maintain recovery from substance misuse through peer relationships. Recovree provides services to support the health and wellness of employees including on-demand access to recovery coaches with lived-experience, comprehensive chemical health assessments, and incident response planning. Employees struggling with drug and alcohol addiction can have a significant impact on a company`s productivity, safety and culture. Our services help employers retain top talent, improve the health and wellness of their teams and provide better access to resources for people who need help now. Check out our Recovery Friendly Workplace Toolkit, where we introduce you to the disease of substance use disorder, its impact in the workplace, and how to create and support a recovery friendly workplace. Our goal is to provide you with practical tools and information that you can implement within your company. We want to help you improve the lives of your employees and save money.

Homestead Village

Homestead Village is a Pensacola, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Advisory Board

The Advisory Board is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

International Medical Equipment

International Medical Equipment is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.